Rapport Financial Statements From 2010 to 2026
| RAPP Stock | | | 26.97 0.11 0.41% |
Analyzing historical trends in various income statement and balance sheet accounts from Rapport Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rapport Therapeutics' valuation are summarized below:
Market Capitalization | Earnings Share |
There are currently one hundred seven trending fundamental ratios for Rapport Therapeutics that can be evaluated and compared over time across competitors. Investors and active traders are advised to check out Rapport Therapeutics' recent fundamental performance against the performance between
2010 and 2026 to make sure the trends are evolving in the right direction. As of 01/16/2026,
Market Cap is likely to grow to about 4.3
B. Also,
Enterprise Value is likely to grow to about 4.2
BCheck out the analysis of
Rapport Therapeutics Correlation against competitors.
Rapport Therapeutics Balance Sheet | | |
|
Rapport Therapeutics Income Statement | | |
|
Rapport Therapeutics Cash Flow Statement | | |
|
Financial Ratios | | |
|
Rapport Therapeutics Valuation Data | | |
|
Rapport Fundamental Market Drivers
About Rapport Therapeutics Financial Statements
Rapport Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Rapport Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Rapport Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Rapport Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
Pair Trading with Rapport Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rapport Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Rapport Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rapport Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rapport Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rapport Therapeutics Common to buy it.
The correlation of Rapport Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rapport Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rapport Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rapport Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Additional Tools for Rapport Stock Analysis
When running Rapport Therapeutics' price analysis, check to
measure Rapport Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapport Therapeutics is operating at the current time. Most of Rapport Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Rapport Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapport Therapeutics' price. Additionally, you may evaluate how the addition of Rapport Therapeutics to your portfolios can decrease your overall portfolio volatility.